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Abstract
Introduction Despite continuing efforts to reduce tobacco
use in the USA, decline in smoking rates have stalled
and smoking remains a major contributor to preventable
death. Implementation science could potentially improve
uptake and impact of evidence-based tobacco control
interventions; however, no previous studies have
systematically examined how implementation science has
been used in this field. Our scoping review will describe
the use of implementation science in tobacco control in
the USA, identify relevant gaps in research and suggest
future directions for implementation science application to
tobacco control.
Methods and analysis Our team, including a medical
research librarian, will conduct a scoping review guided
primarily by Arksey and O’Malley’s methodology. We
will search English language peer-reviewed literature
published from 2000 to 31 December 2020 for terms
synonymous with ‘tobacco use’, ‘prevention’, ‘cessation’
and ‘implementation science’. The databases included in
this search are MEDLINE (PubMed), Embase (Ovid), CINAHL
(EBSCOhost), PsycINFO (ProQuest), ERIC (ProQuest) and
the Cochrane Library (Wiley). We will include cohort and
quasi-experimental studies, single-group experiments
and randomised trials that report qualitative and/or
quantitative data related to applying implementation
science to the planning and/or delivery of interventions to
prevent or decrease the use of tobacco products. Studies
must target potential or active tobacco users, intervention
providers such as educators or healthcare professionals,
or US policy-makers. A minimum of two reviewers
will independently examine each title and abstract for
relevance, and each eligible full text for inclusion and
analysis. Use of implementation science, demonstrated
by explicit reference to implementation frameworks,
strategies or outcomes, will be extracted from included
studies and summarised.
Ethics and dissemination This study is exempt from
ethics board approval. We will document the equity-
orientation of included studies with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses-
Equity Extension checklist. Results will be submitted for
conferences and peer-reviewed journals.

Strengths and limitations of this study
►► This scoping review protocol describes the approach

to an investigation of the explicit use of implementation science in planning and/or delivering tobacco
control interventions in the USA to reduce the prevalence of preventable diseases and deaths.
►► This proposed review focuses on databases that are
widely used by investigators who could benefit from
learning about the application of implementation
science in tobacco control research programmes.
►► The study is designed to capture a comprehensive
range of tobacco control programmes.
►► The reviewers developed a logic model depicting
the intersection of tobacco control interventions and
implementation science to support the relevance of
this study for improving population health and reducing tobacco-related health disparities.
►► A limitation of the proposed study is that it is restricted to interventions in the USA. Studies that may
meet inclusion criteria except for this element will be
identified and considered for a later review.

Trial registration number Open Science Framework
Registry (6YRK8).

INTRODUCTION
Tobacco use is the leading preventable cause
of mortality in the USA and is associated
with a wide variety of poor health outcomes
and health disparities.1 Over the past 50
years, researchers and funding agencies have
focused on developing and disseminating
evidence-based programmes to prevent and
reduce tobacco use and exposure to tobacco
smoke.2 Community-based programmes that
coordinated with state and national policies
have been identified as most effective for
achieving public health goals of reducing
tobacco use,2 and clinical practice guidelines
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have been developed to treat tobacco dependence among
current tobacco users.3
Guidance regarding best practices for reducing tobacco
use globally and in the USA has been available for
decades. The WHO’s Framework Convention on Tobacco
Control,4 and the related MPOWER website,5 focus on
national policies, including steps that reduce demand for
tobacco products and exposure to second-hand smoke,
and support cessation. Best practices for addressing
tobacco use, provided by Centers for Disease Control
and Protection (CDC)2 include goals and strategies that
are similar to those of the WHO. Similarly, an Institute
of Medicine committee report related to smoking cessation in the military6 outlined best practices that included
establishing tobacco-free spaces and supporting tobacco
use cessation.
Although tobacco use in the USA has declined since
the first surgeon general’s report linking it to lung cancer
and other diseases in 1964,1 the decrease in cigarette use
plateaued early in the last decade.7 Recent trends show
that tobacco product use, including nicotine delivery
via cigarette alternatives, is on the rise.8 Furthermore,
observed declines in tobacco use have occurred disproportionately among populations with more education,
better health status, skilled jobs and higher household
incomes, increasing disparities in health outcomes.9
Lags in effective translation of evidence to practice are
common across health-
related conditions, and can be
addressed by applying best practices in implementation
science.10 Implementation science is the use of scientific methods in studying the uptake and integration of
evidence-based interventions into routine practice in non-
research environments to improve the quality and benefit
of those interventions.11 12 This field examines facilitators
and barriers to establishing and sustaining evidence-
based programmes in particular contexts to achieve
specific implementation outcomes.13 Implementation
science offers enhanced understanding of ways implementation strategies (such as developing a formal plan
for implementing an intervention, or providing ongoing
consultation to those who deliver the intervention14) that
can be tested and successfully applied in varied contexts
to maximise successful intervention outcomes.15
Implementation science resources include, for example,
theoretically informed frameworks and models,16 17
implementation strategies14 and measures of implementation processes and outcomes.18 19 The use of implementation science to enhance the impact of tobacco control
programmes and policies has been identified as a priority
for promoting prevention of tobacco use and cessation in
the US population, especially among socioeconomically
disadvantaged tobacco users.20 21
Although implementation science is a young field,
it has been applied across the cancer continuum.22
However, despite prioritisation of applying implementation science to improve public health, a review of ways
in which implementation science has been used to plan
and deliver tobacco control programmes and policies has
2

not been previously published. Rosen et al23 examined 46
systematic reviews of tobacco control-
related interventions and noted that variability in implementation quality
limits reviewers’ ability to interpret intervention effectiveness. A systematic review was conducted of studies that
reported implementation strategies for a range of chronic
disease prevention interventions, with control groups,
and among the three studies that met their inclusion
criteria, none focused on tobacco-related interventions.24
A recent scoping review25 described targeted populations
and settings for tobacco control interventions, and found
cessation interventions were the most common topics of
systematic reviews. The authors suggested that the focus
on cessation reflects an incomplete approach to tobacco
control as recommended by the WHO.4 The authors indicated they plan to publish their observations regarding
implementation challenges associated with cessation
interventions.
A review of studies on smoking cessation interventions
noted a failure to increase rates of tobacco cessation
despite advances in pharmacotherapy and programmes
demonstrated to be effective in research settings.26 The
authors noted a lack of conclusive research as to whether
this is due to insufficient reach of effective interventions,
reduced effectiveness when programmes are translated
to community settings or populations of community
smokers for whom available interventions are less effective. Surgeon General, David Satcher, described many
effective interventions that have been developed for
advancing tobacco control and said, ‘The challenge to
public health professionals, healthcare systems and other
partners in our national prevention effort is to implement these proven approaches’ (U.S. Department of
Health and Human Services,1 p12). This scoping review
was undertaken to identify explicit use of implementation
science across a comprehensive range of interventions as
described by the WHO and the CDC2 to gauge the awareness of this field’s potential contributions for improving
effective use of tobacco control interventions.
In our preliminary search for published reports of the
use of implementation science in planning and delivering tobacco control interventions, we considered projects described in PROSPERO, the Joanna Briggs Institute
(JBI) Database of Systematic Reviews and Implementation
Reports, and scoping reviews registered in the Center for
Open Science. We found no existing or ongoing scoping
reviews on the use of implementation science in tobacco
control intervention research. The initial search by our
medical librarian team member identified approximately
4500 titles, and we noted that a significant number of
studies were conducted completely outside of the USA.
Studies that describe the explicit use of implementation science tools appeared rarely in the initial samples
of articles we reviewed. We opted to consider studies
across a comprehensive range of tobacco use interventions because the focus of our review is on the application of implementation science rather than specific types
of interventions or goals. Our initial screening suggests
Selove R, et al. BMJ Open 2020;10:e038617. doi:10.1136/bmjopen-2020-038617
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Figure 1

Logic model underlying tobacco control programme implementation scoping review.

that the number of studies that will qualify for inclusion
will be manageable for data extraction and meaningful
synthesis of the findings.
Describing the ways in which implementation science
has been used in tobacco control interventions is essential to gain an understanding of the state of the field
regarding the use of frameworks, models and strategies
that can further reduce tobacco use rates and inequities.
Thus, our goal is to examine peer-reviewed, published
reports of tobacco control interventions in the USA to
identify the use of implementation science in planning
and/or delivering these interventions from 2000 through
31 December 2020. We developed a logic model to depict
the rationale for this project, following the recommendations of Anderson et al27 (figure 1).
This study will describe the nature of the use of implementation science frameworks and models, implementation strategies and measurement of implementation
outcomes in research efforts to prevent tobacco use
and second-hand smoke exposure and/or to promote
smoking cessation. Results from this scoping review can be
used to inform a research agenda for addressing gaps in,
and advancing the application of implementation science
in tobacco control to achieve greater impact, especially in
addressing tobacco-related health disparities.28

►

Review questions
The primary research question for this scoping review
is: How has implementation science been used in planning and delivering tobacco control interventions in the
USA from 2000 to 31 December 2020? Our focus will be
on ways researchers investigated the use of implementation science to plan and deliver tobacco control interventions. The inclusion criteria listed in table 1 describe
specific elements of implementation science that will
qualify studies to be examined in this review. The study is
designed to address the following questions:

►
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►

►
►

What aspects of implementation science (such as use
of implementation science frameworks and models,
implementation strategies, and measurement of
implementation processes and outcomes) appear
explicitly in reports of tobacco control intervention
studies?
What types of interventions (ie, public health interventions such as classroom-based prevention education, tobacco use policies and electronic prompts for
providers, as well as programmes that target individuals and families such as group counselling and text
messages to support smoking cessation) are associated
with explicit use of implementation science?
What intervention goals (as described in table 2) are
associated with the use of implementation science?
Given the kinds of interventions that the proposed
study identifies that have been planned and delivered
with the benefit of implementation science, where are
there gaps in implementation research? Specifically,
in considering the dimensions of comprehensive
tobacco control offered by the WHO4 and the CDC,2
are there kinds of interventions that less frequently
used implementation science tools in planning and/
or delivery, where less is known about how implementation factors affected behavioural and clinical
outcomes?
Have the number of peer-reviewed published studies
explicitly using implementation science changed over
the past 19 years?

METHODS
The process for this scoping review will follow the guidance provided in Arksey and O’Malley’s29 seminal paper,
as well as the JBI30 31 and other expert recommendations.32 The steps are: (1) identify a research question;
(2) identify relevant published studies; (3) select studies
that will be included in the scoping review, using clearly
3
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Table 1 Criteria for review of full texts for inclusion in study
Inclusion

Exclusion

► Article was published between 2000 and 31 December

►
►
►
►
►
►
►
►

2020.
► Study was conducted inside of USA (may include other
countries as well, as long as USA is named also).
► The implementation of a tobacco control intervention or
programme was studied.
1. Implementation science was explicitly used. The
authors:described planned actions to promote human
behaviour change in order to integrate tobacco control
interventions into educational, community or clinical
settings,
2. considered organisational constraints and facilitators that
could affect uptake and delivery of the intervention, and
3. collected data regarding the processes and/or outcomes of
their planned actions.
4. Data related to implementation science questions were
collected and analysed.
 Explicit use is further defined as reference to use of
implementation science, knowledge translation or transfer,
a specific implementation science framework or model,
implementation strategies, assessment of implementation
stages or implementation outcomes. Other elements may
be included if they emerge in the course of the review.

articulated inclusion and exclusion criteria; (4) extract
data from each study to address the research questions
and (5) summarise and disseminate the results of the data
extraction and review process.
Patient and public involvement
No patient involvement was obtained in designing this
scoping review protocol.
Search strategy
In consultation with our team’s medical research librarian,
and following JBI guidelines, a three-step search strategy
will be used.30 The first step, an initial pilot search, was
performed in MEDLINE (PubMed) in 2017. Second,
additional search terms were added on review of the initial
results and input from subject experts. The databases to be
included in this search are MEDLINE (PubMed), Embase
(Ovid), CINAHL (EBSCOhost), PsycINFO (ProQuest),
ERIC (ProQuest) and the Cochrane Library (Wiley). All
searches are limited to English language and publication
dates from 1 January 2000 to 31 December 2020. The
MEDLINE (PubMed) search strategy is defined in box 1.
Full details for the search strategy are provided in the
online supplemental appendix 1.
Study selection
All identified references will be uploaded into Covidence
systematic review software (Veritas Health Innovation,
Melbourne, Australia). Duplicate citations will be removed
using the Covidence software. Each title and abstract will
be reviewed for relevance by two of the study authors. At
the title and abstract screening phase, studies that will be
included must describe a tobacco control intervention
4

Completely outside of the USA
Dissertation or thesis
Essay or opinion piece
Study protocol only
Only describes guidelines
Report of a conference presentation
Book
Does not describe implementation of a tobacco control
intervention
► Analysis of secondary surveillance or cross-sectional data
by authors not involved in delivering intervention
► No indication that implementation science elements were
used

conducted in the USA, and be published between 2000
and 31 December 2020. Conflicts regarding inclusion for
full-text review will be resolved by the senior author (RS)
and through team discussion where necessary.
During the initial title and abstract screen, relevant
systematic reviews will be identified for hand searching.
For titles found through hand searches of systematic
reviews that are not already in the original data set, the
associated abstracts will be reviewed by two of the study
authors using the same inclusion and exclusion criteria
given in table 1. Full texts will be retrieved for final
eligibility screening using the inclusion and exclusion
criteria presented below. Each full text will be reviewed
for inclusion in the final study by two members of the
study team, with conflicts resolved through team discussion. During full-text reviews, members of the study team
will hand search for citations of related publications that
might provide more complete descriptions of the tobacco
control intervention. Titles and abstracts of publication
identified by hand searches will be reviewed by two
members of the study team as described above.
Inclusion criteria
We will use the population-concept-context framework
described by the scoping review guidelines of the JBI30
as one dimension of our inclusion criteria. Based on the
variety of tobacco control interventions, we expect that
populations represented in included studies will vary.
Tobacco control interventions are designed to prevent
use, as well as reduce primary and secondary exposure
to tobacco. Thus, study populations can include non-
smokers, combustible tobacco and smokeless tobacco
Selove R, et al. BMJ Open 2020;10:e038617. doi:10.1136/bmjopen-2020-038617
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Table 2 Tobacco control programmes/interventions: goals, target audience and components
Programme goals
Programme/intervention components
at two levels

Promote
Eliminate
Increase Eliminate disparities
tobacco-
Prevent second-hand
tobacco in tobacco use
free culture initiation smoke exposure cessation treatment

Public health interventions: society (government and industry); community (eg, healthcare providers, schools and educators,
housing complexes and workplaces/retailers)
PH1
PH2
PH3
PH4
PH5
 Policy interventions
►
Tobacco use restrictions such as bans in
restaurants, work places, parks and cars with
child passengers
►
Multiuse housing bans
 Communication interventions
 Mass media campaigns:
 Harms of tobacco use,
 Availability of state QuitLine counselling,
►
Self-help programmes on radio, TV, web,
blogs, billboards and leaflets
 Promoting access to tobacco cessation
medications
 Education in schools, workplaces and public
spaces

PH6

PH7

PH8

PH9

PH10

 Provider/teacher education
 Training for physician, nurse, pharmacist,
dentist and teacher
 Electronic/written prompts to check tobacco
use status

PH11

PH12

PH13

PH14

PH15

 
Tobacco
screening/other intervention
guideline

PH16

PH17

PH18

PH19

PH20

Individual interventions: family, individual adults, children and youth
 Communication interventions
 Text messages for quitting
 Web-based media literacy education

I21

I22

I23

I24

I25

 
Behavioural
therapies and medication
I26
 Brief advice from healthcare provider-3 or 5
A’s
 Provider referral to QuitLine
 Multisession QuitLine counselling
 Face-to-face group and individual counselling
 Food and drug administration-approved
medications and NRT
 App and web-based programmes
 Cessation programmes for special populations I31
 Homeless people, smokers with mental health
and/or substance use disorders, cancer
survivors, ethnic minorities and pregnant
women

I27

I28

I29

I30

I32

I33

I34

I35

NRT, nicotine replacement therapy.

users, and individuals exposed to second-hand smoke.
These populations include persons of all races and ethnicities, and range in age from infants to older adults.9 33
Targets of tobacco control interventions include pregnant women, school children, parents, healthcare
providers, smoking cessation counsellors, teachers, public
health workers, policy makers, media stakeholders and
proprietors of establishments that sell tobacco products
Selove R, et al. BMJ Open 2020;10:e038617. doi:10.1136/bmjopen-2020-038617

or regulate exposure to tobacco smoke. With regard to
contexts, tobacco control interventions are delivered in
a wide variety of settings, including healthcare providers’
offices, hospitals, classrooms, daycare centres, after-
school programmes, community centres, faith communities and more. Because of this diversity, we will not
exclude studies based on participant characteristics or
programme settings.
5
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Box 1

Search strategy for MEDLINE (PubMed)

(“Tobacco Products”(MeSH) OR “Tobacco Use”(MeSH) OR “Tobacco
Smoke Pollution” (MeSH) OR “Smoking”(MeSH) OR tobacco (tiab) OR
tobacco use (tiab) OR smoking (tiab) OR second handsecondhand
smoke exposure (tiab) OR second handsecondhand smoke (tiab) OR
tobacco use initiation (tiab) OR smoking initiation (tiab) OR “Tobacco
Use Cessation”(MeSH) OR tobacco control (tw) OR “smoking cessation” (MeSH Terms) OR smoking cessation (tw)) AND (“Smoking
Prevention”(MeSH) OR smoking prevention (tw) OR “Health Promotion”
(MeSH) OR health promotion (tw) OR “Health Education” (MeSH) OR
health education (tw) OR programprogramme (tw) OR programsprogrammes (tw) OR intervention (tw) OR interventions (tw) OR ‘Policy’
(MeSH) OR “Smoke-Free Policy” (MeSH) OR “Social Control Policies”
(MeSH) OR “Organizational Organisational Policy” (MeSH) OR “Public
Policy” (MeSH) OR policy (tw) OR policies (tw) OR public policy (tw) OR
health policy (tw)) AND (implementation science (tw) OR implementation(tw) OR “diffusion of innovation” (MeSH Terms) OR implementation
frameworks (tw) OR implementation models (tw) OR implementation
study (tw) OR translational research (tw) OR “translational medical
research” (MeSH Terms) OR knowledge translation (tw)) AND (Clinical
Trial (ptyp) OR Comparative Study (ptyp) OR Controlled Clinical Trial
(ptyp) OR Evaluation Studies (ptyp) OR Observational Study (ptyp)
OR RandomizedRandomised Controlled Trial (ptyp) OR “Qualitative
Research” (MeSH) OR “Prospective Studies” (Mesh) OR “Cohort
Studies” (MeSH) OR Meta-Analysis (ptyp) OR systematic (sb) OR evaluation studies (ptyp) OR evaluation studies (tw) OR clinical trial (tw)
OR comparative study (tw) OR observational study (tw) OR qualitative
research (tw) OR “programprogramme evaluation” (MeSH Terms) OR
programprogramme evaluation (tw) OR hybrid design (tw) OR experimental (tw) OR mixed methods study (tw)) AND (“2000/01/01” (PDAT) :
“2020/12/31” (PDAT)) AND English (lang)

This study will examine the intersection of two key
concepts: tobacco control programmes and implementation science. For this study, tobacco control programmes
or interventions are defined as activities that aim to
achieve one or more of the following goals: (1) promote
tobacco-free culture; (2) prevent initiation of tobacco use;
(3) eliminate second-hand smoke exposure; (4) increase
tobacco cessation; or (5) eliminate disparities in tobacco
use treatment.4 6 34 Examples of such interventions
include, but are not limited to, public health interventions (eg, taxation, mass media campaigns, tobacco use
restrictions or policies relevant to tobacco retail environments) or individual-level interventions (eg, healthcare
provider training, tailored communication interventions,
pharmacotherapy or structured counselling).2 We drew
from the CDC’s best practices for tobacco control,2 the
WHO’s Framework Convention on Tobacco Control4 and
the related MPOWER website,5 and an Institute of Medicine committee report related to smoking cessation in
the military,6 to develop a matrix of tobacco control interventions presented in table 2. We will use this matrix to
categorise reports of interventions to address Objective 3,
and will compare our results to those of Halas et al25 who
found that tobacco use cessation was the most common
goal of studies they examined.
6

The inclusion criteria for use of implementation
science were developed by reviewing seminal writings
in the field, for example,10 13 14 17 and operational definitions reported in a scoping review of implementation
science associated with nursing interventions in German-
speaking countries.35 We also asked five leading scholars
in the implementation science field how they would
determine if a study should be included in this scoping
review. This led to identification of three broad elements
for determining that implementation science was used:
investigators (1) described planned actions to promote
human behaviour change in order to integrate evidence-
based tobacco control interventions into educational,
community or clinical settings, (2) considered organisational constraints and facilitators that could affect uptake
and delivery of the intervention, and (3) collected data
regarding the processes and/or outcomes of their
planned actions.
To address research question 1 (What aspects of implementation science appear in the studies?), the multidisciplinary scoping review team reviewed a sample of
articles that would be considered for the scoping review,
and identified two categories of implementation science
use: tier 1 and tier 2. Tier 1 studies include elements that
are explicitly labelled as implementation science, such
as: use of a specific implementation science framework
such as the Interactive Systems Framework,36 or an implementation toolkit37 38 for planning adoption of an intervention; use of specific implementation strategies14 39 for
enhancing delivery of an intervention; measuring stages
of implementation40 41 during the process of delivering
an intervention; or measurement of implementation
outcomes as articulated by Proctor et al13 as part of evaluating an intervention.
Implementation outcomes of interest include, but are
not limited to, rates of intervention adoption, acceptability to patients, feasibility, appropriateness, costs,
fidelity, penetration and sustainability;13 or broader
service outcomes assessing processes of care such as safety,
timeliness, efficiency, effectiveness, equity or patient-
centeredness.13 42 Provider acceptability, self-efficacy for
delivering an intervention as well as satisfaction with
outcomes of an intervention will also be considered as
aspects of implementation science, among variables that
may be associated with implementation outcomes43 as
listed previously. Multiple definitions and terminologies
are used globally to convey the use of science to translate
evidence-based research into practice,44 45 for example,
knowledge translation and translation of research into
practice, and investigators may use these terms to refer to
such planned activities.38 46
We anticipate that we will find peer-reviewed articles
indicating that investigators assessed implementation
facilitators and barriers,43 such as attitudes of key stakeholders toward a proposed intervention, organisational
capacity for accommodating a new intervention, or
community readiness to adopt and implement a tobacco-
related policy, without explicitly describing their work as
Selove R, et al. BMJ Open 2020;10:e038617. doi:10.1136/bmjopen-2020-038617
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implementation science. We will tag these tier 2 articles
for a separate review.
This review will include studies published between
2000 and 31 December 2020. We chose the year 2000 as
it represents the beginning of ‘preparation’47 for application of the resources of the emerging field, and the early
stage of an era when implementation research and implementation science began expanding as a focus in the
peer-reviewed literature.48 49 We will limit our review to
studies conducted in the USA because policies, laws, regulations (eg, on advertising) and cultural norms related to
tobacco vary widely across countries and regions of the
world. This inclusion criteria reduces the heterogeneity
of contextual factors, which are prime considerations for
implementation science,49 and enhances the feasibility of
our undertaking. Studies conducted only outside the USA
that may meet all other criteria for this scoping review will
be identified for a future project.
Qualitative and quantitative empirical studies published
in peer-reviewed journals will be eligible for inclusion.
Study designs may include prospective cohort studies,
natural experiments, quasi-experimental studies, single-
group experiments and/or randomised controlled trials.
Studies will be eligible if they report on primary data
collection related to the process of implementing an
intervention, whether or not they report evaluation of the
effectiveness of the intervention. Dissertations, theses,
reports of conference presentations, letters, guidelines,
grey literature and books will be excluded, as we are
limiting the review to publications that are more readily
accessible to the broader scientific and practitioner
community. As we are interested in articles in which use of
implementation science is readily apparent to researchers
and practitioners, we will not seek additional information
from authors to investigate use of implementation science
that is not reported in their published work.
Assessment of methodological quality
The purpose of this review is to identify how implementation science has been used across a wide range of study
designs in tobacco control research. We do not plan to
assess the methodological quality of the interventions
themselves or provide a summary of what kind of interventions are effective. We plan to describe findings regarding
the explicit application of implementation science
including frameworks and models, strategies, assessment
and measurement of implementation barriers and facilitators, stages and outcomes. Our critical appraisal will
focus on uses and gaps of implementation science in
included studies.30
Extraction of results
Once full texts to be included in the scoping review have
been identified, two members of the study team will independently extract study characteristics from each one
using a structured data extraction form in Covidence.
Elements to be extracted include: (a) characteristics of
the population targeted by the intervention, including
Selove R, et al. BMJ Open 2020;10:e038617. doi:10.1136/bmjopen-2020-038617

sex, age, tobacco use status, ethnicities and roles (such as
dentists or nurses, pregnant women and policy makers);
(b) context in which the intervention is implemented,
such as classroom, hospital, multiunit housing and county;
(c) specific types and goals of interventions as categorised
in table 2, as well as if and how the authors described the
evidence-base for the intervention; (d) what aspects of
implementation science were used in the design, delivery
and/or evaluation of the intervention, such as specific
implementation frameworks or models, implementation
strategies, or measurement of intervention processes
or outcomes; and (e) contributions of implementation
science to the study if identified by the study’s authors.
Discrepancies in extracted responses will be resolved
through team discussion when necessary. The data
extraction process will be trialled by the study team prior
to execution to ensure consistency and relevance of fields
before proceeding to full data extraction.
Data synthesis
Following data extraction, frequencies of study characteristics will be calculated where possible. In addition, the
study team will conduct a narrative synthesis50 of characteristics of populations, content and contexts in included
studies. The purpose of this analytic approach is to tell
a story about use of implementation science in tobacco
control research in the USA, including description of
patterns that may emerge, such as target audiences, intervention goals or settings associated with implementation
science use, as well as the impact of its use. The critical
reflection required in this process has the potential for
generating hypotheses50 regarding evolution of the use of
implementation science in this field. A meta-analysis will
not be conducted, as this will not be necessary to address
the research question.
Potential implications of findings
Preliminary reviews of full text suggest that implementation science has not been used extensively in efforts to
prevent and reduce tobacco use in the USA. We anticipate that the results of this scoping review will contribute
to the knowledge base of implementation researchers
in describing the extent and nature of implementation
science application to public health and individual levels
of tobacco control (table 2). This study will also provide
investigators who implement tobacco control interventions across the range of goals described by the CDC and
the WHO,4 with examples of studies that are informed by
implementation science, as well as gaps in applications
from this field. As the scoping review will include almost
two decades of research, we anticipate that we will identify
trends in implementation science use in tobacco control
intervention research as the field has matured over time.
Ethics and dissemination
One goal of this study is to contribute to improvement in
tobacco control interventions in reducing health disparities (figure 1). Efforts to promote effective tobacco control
7

Open access
reflect commitments to social justice51 and implementation science can substantially improve the outcomes of
these efforts. We will document the equity-orientation of
included studies with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)-Equity
Extension checklist.52
The findings from this study will be disseminated via
peer-reviewed publications and conference presentations
for audiences interested in tobacco control and implementation science. All results will be prepared in accordance with JBI guidelines30 and checklists for PRISMA,53
the Extension for Scoping Reviews (PRISMA-ScR)52 and
equity reporting.54 A PRISMA flow diagram53 will indicate
the numbers of articles identified in each search method,
duplicates removed, and number of studies excluded and
included, along with reasons for exclusion at the full-text
review level. The main findings will be presented using
tables and a narrative description that will detail the
results in view of the objectives and research questions of
the scoping review. A list of the included studies, along
with their key characteristics, will be provided in the
primary manuscript reporting the results of this review.
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